Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/1996
08/27/1996US5550162 N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide derivatives, their preparation and their therapeutic use
08/27/1996US5550143 Heterocyclic compounds
08/27/1996US5550125 Brain disorders
08/27/1996US5550124 Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease
08/27/1996US5550118 Polyhydronorharman synthase inhibitors
08/27/1996US5550116 Anticoagulants
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025414A1 Imidazo[1,2-a]pyridines for the treatment of cns and cardiac diseases
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025184A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025176A1 Therapeutic inhibitor of vascular smooth muscle cells
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
08/21/1996EP0727425A1 Adhesion receptor antagonists
08/21/1996EP0727417A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds as well as medicaments containing them
08/21/1996EP0727416A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them
08/21/1996EP0727214A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996EP0727213A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996EP0727212A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
08/21/1996EP0727210A2 Analgesic agent and its use
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726900A1 7H-IMIDAZO(1,2-a)PYRAZINE-8-ONE NMDA RECEPTOR ANTAGONISTS
08/21/1996EP0726899A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
08/21/1996EP0726898A1 Phenylindole compounds
08/21/1996EP0726896A1 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726894A1 Short-acting dihydropyridines
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726766A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
08/21/1996EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
08/21/1996EP0584186B1 Receptor ligands
08/21/1996CN1129451A Vasocontrictive dihydrobenzopyran derivatives
08/21/1996CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/21/1996CN1129441A Vitamin D analogues
08/21/1996CN1129440A Phenoxyphenyl cyclopentenyl hydroxyureas
08/21/1996CN1129401A Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions
08/21/1996CN1129219A Pharmaceutical compounds
08/21/1996CN1129216A Hydroxamic acid derivatives with tricylic substitution
08/21/1996CN1129118A Compounded preparation of notoginseng
08/20/1996US5547970 Use of leflunomide for inhibiting tumor necrosis factor alpha
08/20/1996US5547968 Treatment of ocular hypertension with a synergistic combination
08/20/1996US5547953 Antiarrhythmia agents, antiischemic agents, antigrowth agents
08/20/1996US5547656 Low density microspheres and their use as contrast agents for computed tomography, and in other applications
08/20/1996CA2019324C Fosinopril tablet formulations
08/18/1996CA2169717A1 Method for the manufacture of diltiazem
08/18/1996CA2168303A1 Azepinone compounds useful in the inhibition of ace and nep
08/16/1996CA2169433A1 Adhesion receptor antagonists
08/15/1996WO1996024604A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996WO1996024596A1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
08/15/1996WO1996024594A1 Benzoxazepine derivatives, salts thereof, and drugs containing the same
08/15/1996WO1996024373A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996WO1996024372A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/15/1996WO1996024348A2 Use of carbazole compounds for the treatment of congestive heart failure
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2212731A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/15/1996CA2212713A1 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
08/15/1996CA2212712A1 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
08/14/1996EP0726520A2 Disk array having redundant storage and methods for incrementally generating redundancy as data is written to the disk array
08/14/1996EP0726267A1 Quinazoline derivative
08/14/1996EP0726250A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
08/14/1996EP0726074A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
08/14/1996EP0726072A2 Composition for the treatment of hypertension and congestive heart failure, containing an angiotensin II antagonist and an endopeptidase inhibitor
08/14/1996EP0725798A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas
08/14/1996EP0725794A1 Human monocyte chemoattractant protein-1 (mcp-1) derivatives
08/14/1996EP0725782A1 Novel a 1 adenosine receptor agonists and antiagonists
08/14/1996EP0725781A1 Process for the preparation of substituted thiopyran-1-oxides
08/14/1996EP0725779A1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
08/14/1996EP0725655A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0533828B1 Pgf 1-alcohols and their use as ocular hypotensives
08/14/1996CN1129000A New compound and its prepn.
08/14/1996CN1128762A Benzyl piperidine derivatives
08/14/1996CN1128757A 1,4-dihydro pyridine-3,5-dicarboxylic ester
08/14/1996CN1128756A Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatves as selective human NK3-receptor antagonists
08/14/1996CN1128753A Alkyl benzoylguanidines derivatives
08/14/1996CN1128752A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof
08/13/1996US5545838 Hypotensive agents
08/13/1996US5545738 Useful for production of antihypertensive agents and dysurea curing agents
08/13/1996US5545669 Anti-inflammatory compounds
08/13/1996US5545651 Hypotensive agents
08/13/1996US5545646 4-bicyclically substituted dihydropyridines and their use in medicaments
08/13/1996US5545645 Heterocyclic derivatives in the treatment of ischaemia and related diseases
08/13/1996US5545643 Useful for treating diseases of central nervous system
08/13/1996US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation
08/13/1996US5545619 Autoimmune diseases; transplant rejection, reduction in tissue damage associated with myocardial infarctions and strokes; medical diagnosis
08/13/1996US5545569 Immobilizing capture moiety that binds transforming growth factor-beta, adding serum from patient to form capture complex, adding labeled signal moiety that binds with complex, determining detectable label, presence of factor
08/09/1996CA2168066A1 Treatment of hypertension and congestive heart failure
1 ... 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 ... 1595